GREAT POINT PARTNERS LLC Quant / Systematic

CIK: 0001281446 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 16, 2021

Total Value ($000): $476,717 (100.0% shares, 0.0% debt)

Holdings (30)

MGNX MACROGENICS INC 7.8%

Value ($000) $37,026 Shares 1,378,495 Est. Cost $18.17 Unrealized +61.2%

RCKT ROCKET PHARMACEUTICALS INC 7.6%

Value ($000) $36,187 Shares 817,040 Est. Cost $38.30 Unrealized +13.4%

— ARENA PHARMACEUTICALS INC 7.2%

Value ($000) $34,487 Shares 505,670 Est. Cost $60.44 Unrealized —

UTHR UNITED THERAPEUTICS CORP DEL 6.6%

Value ($000) $31,649 Shares 176,406 Est. Cost $100.63 Unrealized +89.3%

PODD INSULET CORP 6.0%

Value ($000) $28,714 Shares 104,600 Est. Cost $257.08 Unrealized +5.7%

EXEL EXELIXIS INC 5.3%

Value ($000) $25,401 Shares 1,394,107 Est. Cost $22.12 Unrealized +5.4%

COLL COLLEGIUM PHARMACEUTICAL INC 4.3%

Value ($000) $20,364 Shares 861,410 Est. Cost $21.69 Unrealized +6.5%

— KADMON HLDGS INC 3.9%

Value ($000) $18,692 Shares 4,830,000 Est. Cost $4.16 Unrealized —

NTLA INTELLIA THERAPEUTICS INC 3.4%

Value ($000) $16,191 Shares 100,000 Est. Cost — Unrealized —

— MIRATI THERAPEUTICS INC 3.4%

Value ($000) $16,153 Shares 100,000 Est. Cost $171.30 Unrealized —

TVTX TRAVERE THERAPEUTICS INC 3.3%

Value ($000) $15,820 Shares 1,084,300 Est. Cost $24.05 Unrealized -18.0%

FOLD AMICUS THERAPEUTICS INC 3.2%

Value ($000) $15,424 Shares 1,600,000 Est. Cost $9.76 Unrealized 0.0%

— SAGE THERAPEUTICS INC 3.0%

Value ($000) $14,203 Shares 250,000 Est. Cost $46.88 Unrealized —

DYN DYNE THERAPEUTICS INC 3.0%

Value ($000) $14,151 Shares 672,559 Est. Cost $18.80 Unrealized 0.0%

— REPARE THERAPEUTICS INC 2.9%

Value ($000) $13,597 Shares 436,089 Est. Cost $31.18 Unrealized —

— FIBROGEN INC 2.8%

Value ($000) $13,315 Shares 500,000 Est. Cost — Unrealized —

OCUL OCULAR THERAPEUTIX INC 2.7%

Value ($000) $13,044 Shares 919,887 Est. Cost $15.51 Unrealized -2.0%

— INTERSECT ENT INC 2.5%

Value ($000) $11,963 Shares 700,000 Est. Cost $19.16 Unrealized —

PBYI PUMA BIOTECHNOLOGY INC 2.5%

Value ($000) $11,934 Shares 1,300,000 Est. Cost $10.19 Unrealized -0.5%

BIIB BIOGEN INC 2.4%

Value ($000) $11,254 Shares 32,500 Est. Cost $269.69 Unrealized +12.3%

— MAGENTA THERAPEUTICS INC 2.3%

Value ($000) $10,867 Shares 1,111,111 Est. Cost $9.78 Unrealized —

KURA KURA ONCOLOGY INC 2.2%

Value ($000) $10,425 Shares 500,000 Est. Cost $24.83 Unrealized 0.0%

ANAB ANAPTYSBIO INC 2.2%

Value ($000) $10,373 Shares 400,051 Est. Cost $23.97 Unrealized 0.0%

OLMA OLEMA PHARMACEUTICALS INC 1.9%

Value ($000) $9,208 Shares 329,086 Est. Cost $28.46 Unrealized 0.0%

— TRICIDA INC 1.8%

Value ($000) $8,528 Shares 1,974,000 Est. Cost $4.49 Unrealized —

IFRX INFLARX NV 1.4%

Value ($000) $6,534 Shares 2,200,000 Est. Cost $5.12 Unrealized -35.2%

— RIGEL PHARMACEUTICALS INC 1.4%

Value ($000) $6,510 Shares 1,500,000 Est. Cost $4.34 Unrealized —

CTMX CYTOMX THERAPEUTICS INC 1.3%

Value ($000) $6,330 Shares 1,000,000 Est. Cost $7.79 Unrealized 0.0%

— AEGLEA BIOTHERAPEUTICS INC 1.3%

Value ($000) $6,264 Shares 900,000 Est. Cost $7.50 Unrealized —

— VERVE THERAPEUTICS INC 0.4%

Value ($000) $2,109 Shares 35,000 Est. Cost $60.26 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MGNX	MACROGENICS INC	1,378,495	$37,026	7.8%	$18.17	+61.2%	COM	556099109
RCKT	ROCKET PHARMACEUTICALS INC	817,040	$36,187	7.6%	$38.30	+13.4%	COM	77313F106
—	ARENA PHARMACEUTICALS INC	505,670	$34,487	7.2%	$60.44	—	COM NEW	040047607
UTHR	UNITED THERAPEUTICS CORP DEL	176,406	$31,649	6.6%	$100.63	+89.3%	COM	91307C102
PODD	INSULET CORP	104,600	$28,714	6.0%	$257.08	+5.7%	COM	45784P101
EXEL	EXELIXIS INC	1,394,107	$25,401	5.3%	$22.12	+5.4%	COM	30161Q104
COLL	COLLEGIUM PHARMACEUTICAL INC	861,410	$20,364	4.3%	$21.69	+6.5%	COM	19459J104
—	KADMON HLDGS INC	4,830,000	$18,692	3.9%	$4.16	—	COM	48283N106
NTLA	INTELLIA THERAPEUTICS INC	100,000	$16,191	3.4%	—	—	Call	45826J105
—	MIRATI THERAPEUTICS INC	100,000	$16,153	3.4%	$171.30	—	COM	60468T105
TVTX	TRAVERE THERAPEUTICS INC	1,084,300	$15,820	3.3%	$24.05	-18.0%	COM	89422G107
FOLD	AMICUS THERAPEUTICS INC	1,600,000	$15,424	3.2%	$9.76	0.0%	COM	03152W109
—	SAGE THERAPEUTICS INC	250,000	$14,203	3.0%	$46.88	—	COM	78667J108
DYN	DYNE THERAPEUTICS INC	672,559	$14,151	3.0%	$18.80	0.0%	COM	26818M108
—	REPARE THERAPEUTICS INC	436,089	$13,597	2.9%	$31.18	—	COM	760273102
—	FIBROGEN INC	500,000	$13,315	2.8%	—	—	Call	31572Q808
OCUL	OCULAR THERAPEUTIX INC	919,887	$13,044	2.7%	$15.51	-2.0%	COM	67576A100
—	INTERSECT ENT INC	700,000	$11,963	2.5%	$19.16	—	COM	46071F103
PBYI	PUMA BIOTECHNOLOGY INC	1,300,000	$11,934	2.5%	$10.19	-0.5%	COM	74587V107
BIIB	BIOGEN INC	32,500	$11,254	2.4%	$269.69	+12.3%	COM	09062X103
—	MAGENTA THERAPEUTICS INC	1,111,111	$10,867	2.3%	$9.78	—	COM	55910K108
KURA	KURA ONCOLOGY INC	500,000	$10,425	2.2%	$24.83	0.0%	COM	50127T109
ANAB	ANAPTYSBIO INC	400,051	$10,373	2.2%	$23.97	0.0%	COM	032724106
OLMA	OLEMA PHARMACEUTICALS INC	329,086	$9,208	1.9%	$28.46	0.0%	COM	68062P106
—	TRICIDA INC	1,974,000	$8,528	1.8%	$4.49	—	COM	89610F101
IFRX	INFLARX NV	2,200,000	$6,534	1.4%	$5.12	-35.2%	COM	N44821101
—	RIGEL PHARMACEUTICALS INC	1,500,000	$6,510	1.4%	$4.34	—	COM NEW	766559603
CTMX	CYTOMX THERAPEUTICS INC	1,000,000	$6,330	1.3%	$7.79	0.0%	COM	23284F105
—	AEGLEA BIOTHERAPEUTICS INC	900,000	$6,264	1.3%	$7.50	—	COM	00773J103
—	VERVE THERAPEUTICS INC	35,000	$2,109	0.4%	$60.26	—	COM	92539P101